Filing
Spy
Filing
Spy
Home
About
SLXP
Salix Pharmaceuticals Ltd
Specialty pharmaceutical company focused on gastrointestinal healthcare
CUSIP: 795435106
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2014 Q2
3 of 4 quarters
Total Value
$356.40M
Total Shares
2.89M
Net Share Change
+1.34M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$356.40M
2.89M
1.6%
ADD
+1.34M
(+86.2%)
Viking Global Investors
$356.40M
2.89M shares
ADD
+1.34M
(+86.2%)
SLXP — Salix Pharmaceuticals Ltd - FilingSpy